Pycha A, Mian C, Posch B, Haitel A, El-Baz M, Ghoneim M A, Marberger M
Department of Urology, University of Vienna, Austria.
J Urol. 1998 Sep;160(3 Pt 1):737-40. doi: 10.1016/S0022-5347(01)62772-1.
Since squamous cell differs from transitional cell cancer regarding histopathology, clinical outcome and etiology, the underlying genetic effects of these 2 tumor types may also be different. We compared numerical aberrations of chromosomes 7, 9 and 17 in bilharzial squamous cell carcinoma, and bilharzial and nonbilharzial transitional cell carcinoma by fluorescence in situ hybridization, and correlated the findings to p53 positivity of the 3 tumor types.
Cystectomy for invasive bladder cancer was performed in 169 men and 51 women with a mean age of 54.8 years (range 28 to 83). Of the 220 patients 100 (45.4%) had histologically verified bilharzial squamous cell carcinoma, 61 (27.7%) bilharzial transitional cell carcinoma and 59 (26.8%) nonbilharzial transitional cell carcinoma. Using fluorescence in situ hybridization cystectomy specimens were evaluated for numerical aberrations of chromosomes 7, 9 and 17, and p53 detection was performed by immunohistochemistry.
Aberrations of chromosome 7 were observed in 79% of the bilharzial squamous cell carcinoma specimens, and 100% and 93.2% of bilharzial and nonbilharzial transitional cell carcinoma specimens, respectively (p = 0.00011). Aberrations of chromosome 9 were seen in 92% of squamous cell carcinoma specimens but in only 52.4% and 60.9% of bilharzial and nonbilharzial transitional cell carcinoma, respectively (p < 0.00001). Aberrations of chromosome 17 were found in only 29% of squamous cell carcinoma specimens, compared to 83.6% and 84.7% aberrations of chromosome 17 in both transitional cell carcinoma groups, respectively (p < 0.00001). The p53 over expression was similar in all 3 tumor types with 82% for squamous cell carcinoma, and 73.7% for bilharzial and 81.3% for nonbilharzial transitional cell carcinoma (not significant, p = 0.5285).
Our data show clear differences between chromosomal patterns of invasive bilharzial squamous cell carcinoma and invasive bilharzial or nonbilharzial transitional cell carcinoma but similar frequencies of p53 over expression in all 3 tumor types. However, aberrations of chromosome 9 were observed in all analyzed groups, which confirms the 2 pathways in the oncogenesis of squamous cell and transitional cell carcinoma at the cytogenetic level as suggested by molecular studies.
由于鳞状细胞癌与移行细胞癌在组织病理学、临床结果和病因方面存在差异,这两种肿瘤类型潜在的基因效应可能也有所不同。我们通过荧光原位杂交比较了血吸虫性鳞状细胞癌、血吸虫性和非血吸虫性移行细胞癌中7号、9号和17号染色体的数目畸变情况,并将结果与这三种肿瘤类型的p53阳性情况相关联。
对169名男性和51名女性进行了浸润性膀胱癌膀胱切除术,患者平均年龄54.8岁(范围28至83岁)。在这220例患者中,100例(45.4%)经组织学证实为血吸虫性鳞状细胞癌,61例(27.7%)为血吸虫性移行细胞癌,59例(26.8%)为非血吸虫性移行细胞癌。使用荧光原位杂交技术评估膀胱切除标本中7号、9号和17号染色体的数目畸变情况,并通过免疫组织化学进行p53检测。
在血吸虫性鳞状细胞癌标本中,7号染色体畸变率为79%,在血吸虫性和非血吸虫性移行细胞癌标本中分别为100%和93.2%(p = 0.00011)。9号染色体畸变在鳞状细胞癌标本中占92%,而在血吸虫性和非血吸虫性移行细胞癌中分别仅占52.4%和60.9%(p < 0.00001)。17号染色体畸变在鳞状细胞癌标本中仅占29%,而在两个移行细胞癌组中,17号染色体畸变率分别为83.6%和84.7%(p < 0.00001)。三种肿瘤类型中p53过表达情况相似,鳞状细胞癌为82%,血吸虫性移行细胞癌为73.7%,非血吸虫性移行细胞癌为81.3%(无显著差异,p = 0.5285)。
我们的数据显示,浸润性血吸虫性鳞状细胞癌与浸润性血吸虫性或非血吸虫性移行细胞癌的染色体模式存在明显差异,但三种肿瘤类型中p53过表达频率相似。然而,在所有分析组中均观察到9号染色体畸变,这在细胞遗传学水平上证实了分子研究提示的鳞状细胞癌和移行细胞癌肿瘤发生的两条途径。